Figure (Figure 1)
Tizanidine Tablet
Product Images NDC 76420-885
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 76420-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Figure 2)
This text appears to be a chart or table showing the improvement in the Ashworth Score at different time points post-dose with different doses of tizanidine and a placebo. The data presented likely compares the effects of 16 mg and 8 mg of tizanidine with a control group receiving a placebo. The Ashworth Score is often used to assess muscle tone in conditions such as spasticity.*
Figure (Figure 3)
Figure (Label 2mg)
Figure (Label 4mg)
Figure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
